← SynDRA
RIMEPORIDE
SynDRA canonical compound SYN0033251 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | SLC9A1 |
|---|
| Mechanism of action | sodium/hydrogen exchanger inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- sodium/hydrogen exchanger inhibitor
Cross-references
Synonyms
- Rimeporida
- EMD-87580
- EMR-204
- EMR-62204
- NHE inhibitors (atrial fibrillation), Merck KGaA
- Sodium/hydrogen exchange inhibitors (atrial fibrillation), Merck KGaA
- N-(2-Methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine
- EMD87580
- RefChem:926709
- N-carbamimidoyl-2-methyl-4,5-bis(methylsulfonyl)benzamide
- Rimeporide [INN]
- Rimeporide free base
- QH6B4V5743
- UNII-QH6B4V5743
- A1E6E
- orb1301893
- SCHEMBL1019630
- SCHEMBL1019633
- SCHEMBL29404681
- SCHEMBL30309010
- C11H15N3O5S2
- GROMEQPXDKRRIE-UHFFFAOYSA-N
- BDBM50637448
- MFCD30533663
- AKOS037515659
- BS-16171
- DA-77463
- HY-19273
- CS-0015014
- NS00069650
- T5319
- EMD-87580, >=98% (HPLC)
- D80911
- 2-methyl-4,5di (methylsulfonyl)-benzoyl-guanidine
- N-(4,5-bismethanesulfonyl-2-methylbenzoyl)guanidine
- N-Carbamimidoyl-4,5-di(methanesulfonyl)-2-methylbenzamide
- N-diaminomethylene-2-methyl-4,5-di(methylsulfonyl)benzamide
Look up RIMEPORIDE in the interactive SynDRA portal →